IRIS
CALABRESE, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.434
AS - Asia 2.845
EU - Europa 2.446
SA - Sud America 586
Continente sconosciuto - Info sul continente non disponibili 310
AF - Africa 160
OC - Oceania 6
Totale 15.787
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.286
SG - Singapore 908
IT - Italia 868
RU - Federazione Russa 829
CN - Cina 716
BR - Brasile 465
VN - Vietnam 306
KR - Corea 220
BD - Bangladesh 200
HK - Hong Kong 199
IE - Irlanda 168
IN - India 114
FI - Finlandia 91
NL - Olanda 91
ZA - Sudafrica 85
FR - Francia 82
DE - Germania 81
CA - Canada 73
GB - Regno Unito 69
MX - Messico 39
SE - Svezia 38
AR - Argentina 36
CI - Costa d'Avorio 30
KE - Kenya 25
AT - Austria 23
EC - Ecuador 22
ES - Italia 22
JP - Giappone 22
IQ - Iraq 20
PL - Polonia 20
ID - Indonesia 16
TR - Turchia 16
CO - Colombia 14
SA - Arabia Saudita 13
CL - Cile 11
CZ - Repubblica Ceca 11
VE - Venezuela 11
PK - Pakistan 10
PY - Paraguay 10
LT - Lituania 9
MY - Malesia 9
IR - Iran 8
JM - Giamaica 8
JO - Giordania 7
PH - Filippine 7
PE - Perù 6
PT - Portogallo 6
UY - Uruguay 6
CH - Svizzera 5
PA - Panama 5
PS - Palestinian Territory 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
NP - Nepal 4
RS - Serbia 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KZ - Kazakistan 3
LB - Libano 3
MK - Macedonia 3
RO - Romania 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UA - Ucraina 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
EE - Estonia 2
ET - Etiopia 2
GD - Grenada 2
GR - Grecia 2
GY - Guiana 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
NG - Nigeria 2
OM - Oman 2
QA - Qatar 2
SI - Slovenia 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BY - Bielorussia 1
CU - Cuba 1
DM - Dominica 1
EG - Egitto 1
GE - Georgia 1
GN - Guinea 1
GP - Guadalupe 1
Totale 15.458
Salva come PNG Salva come JPEG
Città #
Dallas 7.594
Singapore 524
Hefei 340
Milan 250
Moscow 248
Seoul 216
Santa Clara 206
Hong Kong 188
Council Bluffs 180
Dublin 167
Ashburn 157
Beijing 148
San Jose 134
Ho Chi Minh City 114
Los Angeles 92
Rome 83
Siena 76
Johannesburg 73
Hanoi 70
The Dalles 61
New York 55
Lauterbourg 52
Helsinki 48
Bengaluru 45
São Paulo 40
Haarlem 38
Buffalo 37
Florence 37
Columbus 36
Abidjan 30
Chicago 29
Munich 29
Lappeenranta 28
Orem 22
Redondo Beach 22
Nuremberg 21
Naples 18
Chennai 17
Rio de Janeiro 17
Amsterdam 16
Toronto 16
Figino 15
Frankfurt am Main 15
Mexico City 15
Turku 15
Warsaw 15
Houston 14
London 14
Bari 13
Bologna 13
Brooklyn 12
Catania 12
Da Nang 12
Guayaquil 12
Hyderabad 12
Montreal 12
Atlanta 11
Haiphong 11
Salt Lake City 11
Stockholm 11
Turin 11
Vienna 11
Miami 10
Tokyo 10
Brno 9
Charlotte 9
Genoa 9
Manchester 9
Mumbai 9
Philadelphia 9
Phoenix 9
Baghdad 8
Denver 8
Poplar 8
Brasília 7
Ceggia 7
Curitiba 7
Hải Dương 7
Paris 7
Querétaro 7
Seattle 7
Thái Bình 7
Amman 6
Ancona 6
Belo Horizonte 6
Boston 6
Clifton 6
Goiânia 6
Guarulhos 6
Kingston 6
Ottawa 6
Pisa 6
Recife 6
Salvador 6
San Francisco 6
Seravezza 6
São Gonçalo 6
Tampa 6
Tehran 6
Asunción 5
Totale 12.111
Salva come PNG Salva come JPEG
Nome #
009 The transcriptome of Sweet syndrome suggests a pathogenic role of both innate and adaptive immune signaling pathways 7.217
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study 278
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study 266
Advances in the Pathogenesis and Treatment of Rosacea: A Phenotype-Based Therapeutic Approach 217
MAPK15 controls cellular responses to oxidative stress by regulating NRF2 activity and expression of its downstream target genes 205
Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a "real-world", mono-center experience 194
Pso-Reg: a web registry for psoriasis in real life 184
Baricitinib: therapeutic potential for moderate to severe atopic dermatitis 177
Eyelid contact dermatitis: 25-year single-center retrospective study 168
Risk of Skin Cancer in Patients with Psoriasis: Single-Center Retrospective Study Comparing Anti-TNFα and Phototherapy 166
Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris 164
Therapeutic Potential of Targeting the JAK/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition 158
Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose? 156
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still's Disease Registry 154
Line-field confocal optical coherence tomography for the diagnosis of skin carcinomas: real-life data over three years 152
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 151
Characteristics of primary cutaneous lymphoma in Italy: a tertiary care, single-center study 151
Diffuse purpuric pityriasis versicolor: a peculiar presentation 150
Non-Invasive Imaging Including Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Diagnosis of Cutaneous Lymphomas 148
Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin 148
Characterisation of IL-1 family members in Sweet syndrome highlights the overexpression of IL-1β and IL-1R3 as possible therapeutic targets 147
Italian Consensus on the treatment of oral lichen planus 145
Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice 144
Clinical response to brodalumab in a patient affected by refractory SAPHO syndrome 142
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 137
Molecular Characteristics of Sweet Syndrome: A Systematic Review 132
Erfolgreiche Behandlung des therapierefraktären Sweet-Syndroms mit Adalimumab 131
Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease 131
Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases* 129
Efficacy and safety of biologics for hidradenitis suppurativa: A network meta-analysis of phase III trials 128
Belimumab as a potential therapeutic option for bullous systemic lupus erythematosus 125
Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma 125
IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa 123
Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg? 123
Use of JAK Inhibitors in Lichen Planus: An Update 122
Psoriasis and fibromyalgia: a systematic review 122
Short-, mid- and long-term efficacy of dupilumab in moderate to severe atopic dermatitis: a real life multicenter Italian study on 2576 patients 121
Investigational systemic drugs for moderate to severe plaque psoriasis: What’s new? 121
Erythema annulare centrifugum as clinical manifestation of-eosinophilic granulomatosis with polyangiitis 116
Line-field confocal optical coherence tomography in alopecia areata and histopathological correlation 116
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa 116
The corkscrew hairs of tinea capitis through line-field confocal optical coherence tomography 114
Psoriasis and its management in women of childbearing age: tools to increase awareness in dermatologists and patients 114
Sweet syndrome: an update on clinical aspects, pathophysiology, and treatment 113
Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis 111
Tildrakizumab in moderate-to-severe plaque psoriasis: a multicenter, retrospective, real-life study 109
Fibromyalgia and Skin Disorders: A Systematic Review 109
New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis 108
Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients 108
Overview of Atopic Dermatitis in Different Ethnic Groups 107
The role of NLRP1 inflammasome in skin cancer and inflammatory skin diseases 107
Design and development of a systematic validation protocol for synthetic melanoma images for responsible use in medical artificial intelligence 102
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies 101
Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses 100
From Bank Preparation to Clinical Use of Homologous Skin Allografts in Wound Healing: A Sustainable Approach 98
725 Characterizing the transcriptional landscape of pyoderma gangrenosum and its main differential diagnoses 95
Severe and resistant palmar psoriasis successfully treated with risankizumab 94
Successful treatment of pyoderma gangrenosum with composite grafting of acellular dermal matrix and glycerolized skin: a preliminary experience 93
Hyper-IgD syndrome and hidradenitis suppurativa: an intriguing link 90
Recalcitrant Sweet Syndrome successfully treated with adalimumab 88
Novel therapeutic strategies in the topical treatment of atopic dermatitis 87
Upadacitinib dose adjustment in moderate-to-severe atopic dermatitis: insights from a multicenter real-world study 85
Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry 80
117 Indiscernible skin transcriptome in Stevens-Johnson syndrome and toxic epidermal necrolysis induced by immune checkpoint inhibitors and other culprit drugs 74
Upadacitinib for Treatment-Resistant Urticarial Vasculitis: A Case Study and Therapeutic Insight 73
T2-Reg: a regional web registry on Th2-mediated diseases 50
High-throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid 48
Abrocitinib: 1-Year Real-Life Experience From the French OMCCI Registry 29
Totale 15.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.695
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20232 0 0 0 0 0 0 0 0 0 0 0 2
2023/2024511 2 1 1 125 41 61 113 15 26 29 50 47
2024/20252.005 39 80 188 104 190 72 64 141 148 144 169 666
2025/202612.737 427 2.481 5.824 891 805 181 483 234 209 359 353 490
2026/2027532 386 146 0 0 0 0 0 0 0 0 0 0
Totale 15.787